Literature DB >> 15236853

The microbial content of non-sterile pharmaceuticals distributed in Norway.

C Charnock1.   

Abstract

Seventy-seven registered trademark pharmaceuticals and allied products, not required by the relevant monographs to comply with the test for sterility, were investigated for their microbial content. All the products examined complied with current regulations with respect to the numbers and types of microbes isolated, indicating the effectiveness of existing production practices in meeting existing standards. Gram-positive endospore-forming rods accounted for the majority of the bacteria isolated. Gram-negative rods were present for the most part in incidental numbers. However, some of these were of species that have been previously indicated as opportunistic pathogens and which should be considered as objectionable in pharmaceuticals. A number of the isolates showed antibiotic resistances unusual for the species in question.

Mesh:

Year:  2004        PMID: 15236853     DOI: 10.1016/j.jhin.2004.03.016

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Outbreak of intestinal infection due to Rhizopus microsporus.

Authors:  Vincent C C Cheng; Jasper F W Chan; Antonio H Y Ngan; Kelvin K W To; S Y Leung; H W Tsoi; W C Yam; Josepha W M Tai; Samson S Y Wong; Herman Tse; Iris W S Li; Susanna K P Lau; Patrick C Y Woo; Anskar Y H Leung; Albert K W Lie; Raymond H S Liang; T L Que; P L Ho; K Y Yuen
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

2.  Microbiological quality of non-sterile pharmaceutical products.

Authors:  M Ratajczak; M M Kubicka; D Kamińska; P Sawicka; J Długaszewska
Journal:  Saudi Pharm J       Date:  2014-12-08       Impact factor: 4.330

3.  Investigating incidence of bacterial and fungal contamination in shared cosmetic kits available in the women beauty salons.

Authors:  Leila Dadashi; Reza Dehghanzadeh
Journal:  Health Promot Perspect       Date:  2016-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.